poisar

Stocks · News reference

DBV Technologies Q2 EPS $(0.12) Misses $(0.10) Estimate, Sales $700.000K Miss $1.391M Estimate

Jul 16, 2026, 8:03 PMBenzinga Newsdesk

DBV Technologies (NASDAQ:DBVT) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.10) by 20 percent. This is a 61.29 percent increase over losses of $(0.31) per share from

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

DBVT
Source
benzinga
Observed
Jul 16, 2026, 8:03 PM
Checked
Jul 16, 2026, 8:03 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Jul 30, 2026, 9:40 PMDbv Technologies

    DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq

    DBV Technologies announced the sale of approximately $50 million in American Depositary Shares (ADSs) through its At-The-Market program on Nasdaq. The company issued 18,288,220 new ordinary shares (3,657,644 ADSs) at $13.67 per ADS to RA Capital Management through Citizens JMP Securities. The issuance represents a 5.82% dilution to existing shareholders and is expected to close on August 3, 2026.

    Read original at globenewswire-inc
    DBVT
  2. Jul 30, 2026, 9:40 PMDbv Technologies

    DBV Technologies annonce le placement d’ADS pour un montant d’environ 50 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq

    DBV Technologies announced the placement of approximately $50 million in American Depositary Shares (ADS) with RA Capital Management through its At-The-Market (ATM) program on Nasdaq. The company will issue 18.288 million new ordinary shares at $13.67 per ADS, representing a 5.82% dilution to existing shareholders. The transaction is expected to close on August 3, 2026.

    Read original at globenewswire-inc
    DBVT
  3. Jul 17, 2026, 9:00 PMDbv Technologies

    DBV Technologies dépose un prospectus relatif à son Programme At-The-Market (ATM) pour un montant pouvant atteindre 150 millions de dollars

    DBV Technologies has filed a new S-3ASR registration statement with the SEC to renew its at-the-market (ATM) offering program for up to $150 million in American Depositary Shares (ADSs). The company plans to use proceeds primarily for manufacturing capacity expansion, pediatric BLA submissions for peanut allergy treatment, and product development. The program was established with Citizens JMP Securities as the placement agent.

    Read original at globenewswire-inc
    DBVT